» Articles » PMID: 33251388

High Affinity of Host Human MicroRNAs to SARS-CoV-2 Genome: An in Silico Analysis

Overview
Date 2020 Nov 30
PMID 33251388
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronavirus disease 2019 (COVID-19) caused by a novel betacoronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has attracted top health concerns worldwide within a few months after its appearance. Since viruses are highly dependent on the host small RNAs (microRNAs) for their replication and propagation, in this study, top miRNAs targeting SARS-CoV-2 genome and top miRNAs targeting differentially expressed genes (DEGs) in lungs of patients infected with SARS-CoV-2, were predicted.

Methods: All human mature miRNA sequences were acquired from miRBase database. MiRanda tool was used to predict the potential human miRNA binding sites on the SARS-CoV-2 genome. EdgeR identified differentially expressed genes (DEGs) in response to SARS-CoV-2 infection from GEO147507 data. Gene Set Enrichment Analysis (GSEA) and DEGs annotation analysis were performed using ToppGene and Metascape tools.

Results: 160 miRNAs with a perfect matching in the seed region were identified. Among them, there was 15 miRNAs with more than three binding sites and 12 miRNAs with a free energy binding of -29 kCal/Mol. MiR-29 family had the most binding sites (11 sites) on the SARS-CoV-2 genome. MiR-21 occupied four binding sites and was among the top miRNAs that targeted up-regulated DEGs. In addition to miR-21, miR-16, let-7b, let-7e, and miR-146a were the top miRNAs targeting DEGs.

Conclusion: Collectively, more experimental studies especially miRNA-based studies are needed to explore detailed molecular mechanisms of SARS-CoV-2 infection. Moreover, the role of DEGs including STAT1, CCND1, CXCL-10, and MAPKAPK2 in SARS-CoV-2 should be investigated to identify the similarities and differences between SARS-CoV-2 and other respiratory viruses.

Citing Articles

Pattern of Neuroinflammatory miRNAs, C-reactive Protein and Alanine Aminotransferase in Hospitalization In Recovered or Not-recovered COVID-19 Patients.

Keikha R, Hashemi-Shahri S, Jebali A Basic Clin Neurosci. 2024; 15(1):73-80.

PMID: 39291092 PMC: 11403103. DOI: 10.32598/bcn.2022.3342.1.


Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad.

Engin A, Engin E, Engin A Adv Exp Med Biol. 2024; 1460:919-954.

PMID: 39287877 DOI: 10.1007/978-3-031-63657-8_31.


Characterization of the SARS-CoV-2 Genome 3'-Untranslated Region Interactions with Host MicroRNAs.

Frye C, Cunningham C, Mihailescu M ACS Omega. 2024; 9(34):36148-36164.

PMID: 39220490 PMC: 11360049. DOI: 10.1021/acsomega.4c01050.


Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects.

Zhang Y, Chen S, Tian Y, Fu X Front Cell Infect Microbiol. 2024; 14:1407261.

PMID: 38846354 PMC: 11155306. DOI: 10.3389/fcimb.2024.1407261.


Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets.

Liu X, Xiong W, Ye M, Lu T, Yuan K, Chang S Signal Transduct Target Ther. 2023; 8(1):441.

PMID: 38057315 PMC: 10700414. DOI: 10.1038/s41392-023-01669-0.


References
1.
Saetrom P, Heale B, Snove Jr O, Aagaard L, Alluin J, Rossi J . Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res. 2007; 35(7):2333-42. PMC: 1874663. DOI: 10.1093/nar/gkm133. View

2.
Khailany R, Safdar M, Ozaslan M . Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020; 19:100682. PMC: 7161481. DOI: 10.1016/j.genrep.2020.100682. View

3.
Liu M, Guo S, Hibbert J, Jain V, Singh N, Wilson N . CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011; 22(3):121-30. PMC: 3203691. DOI: 10.1016/j.cytogfr.2011.06.001. View

4.
Yoshimoto F . The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. Protein J. 2020; 39(3):198-216. PMC: 7245191. DOI: 10.1007/s10930-020-09901-4. View

5.
OBrien J, Hayder H, Zayed Y, Peng C . Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018; 9:402. PMC: 6085463. DOI: 10.3389/fendo.2018.00402. View